US Authorities Approve Groundbreaking Sickle Cell Treatments, Including One That Uses CRISPR
The United States Food and Drug Administration (FDA) on Friday announced the approval of Casgevy, the first CRISPR gene-editing therapy for sickle cell disease, a debilitating genetic illness that affects over 100,000 Americans, the majority of whom are Black. It is the
Follow Us